Literature DB >> 8114763

Phosphorylation and negative regulation of the transcriptional activator CREM by p34cdc2.

R P de Groot1, R Derua, J Goris, P Sassone-Corsi.   

Abstract

Transcription factors that bind to cAMP-responsive elements (CREs) regulate the expression of target genes in response to activation of the adenylyl cyclase pathway. It is generally thought that activation is obtained through direct phosphorylation by the cAMP-dependent protein kinase-A. We have isolated the gene CRE modulator (CREM), which encodes multiple members of the CRE-binding protein family, by cell-specific alternative splicing. Various isoforms have been characterized, encoding both repressors (CREM alpha, -beta, and -gamma) as well as activators (CREM tau). Here we show that the function of the activator CREM tau is regulated by the p34cdc2 kinase. Multiple serine and threonine residues are phosphorylated in vivo as well as in vitro by p34cdc2. Although there is no effect of p34cdc2-mediated phosphorylation on CREM tau DNA binding, we observed a dramatic effect on the trans-regulatory function. Coexpression of a constitutively active p34cdc2 mutant shows that the trans-activation potential of CREM tau is strongly reduced by p34cdc2. This represents the first example of negative regulation of a transcription factor of this class by p34cdc2.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8114763     DOI: 10.1210/mend.7.11.8114763

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  2 in total

1.  The CREB, ATF-1, and ATF-2 transcription factors from bovine leukemia virus-infected B lymphocytes activate viral expression.

Authors:  E Adam; P Kerkhofs; M Mammerickx; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

Review 2.  Goals for signal transduction pathways: linking up with transcriptional regulation.

Authors:  P Sassone-Corsi
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.